human | Q5 |
P496 | ORCID iD | 0000-0003-1909-402X |
P734 | family name | Dijkshoorn | Q124612008 |
Dijkshoorn | Q124612008 | ||
Dijkshoorn | Q124612008 | ||
P735 | given name | Lenie | Q56597585 |
Lenie | Q56597585 | ||
P106 | occupation | researcher | Q1650915 |
Q46949459 | AFLP fingerprinting for the analysis of genetic diversity within Necator americanus |
Q33397961 | Acinetobacter beijerinckii sp. nov. and Acinetobacter gyllenbergii sp. nov., haemolytic organisms isolated from humans |
Q33491424 | Acinetobacter bereziniae sp. nov. and Acinetobacter guillouiae sp. nov., to accommodate Acinetobacter genomic species 10 and 11, respectively |
Q30661754 | Acinetobacter kookii sp. nov., isolated from soil |
Q30829354 | Acinetobacter parvus sp. nov., a small-colony-forming species isolated from human clinical specimens |
Q40344085 | Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells |
Q28257612 | An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii |
Q35269274 | Carbapenem resistance in a human clinical isolate identified to be closely related to Acinetobacter indicus |
Q42646549 | Characterization of a 2.6 kbp variable region within a class 1 integron found in an Acinetobacter baumannii strain isolated from a horse |
Q40638584 | Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping |
Q34498753 | Clonal diversity and high prevalence of OXA-58 among Acinetobacter baumannii isolates from blood cultures in a tertiary care centre in Turkey |
Q40585230 | Comparison of Acinetobacter baumannii isolates from United Kingdom hospitals with predominant Northern European genotypes by amplified-fragment length polymorphism analysis |
Q34631109 | Cryo-electron tomography analysis of membrane vesicles from Acinetobacter baumannii ATCC19606 T. |
Q33462443 | Description of Acinetobacter venetianus ex Di Cello et al. 1997 sp. nov. |
Q34162588 | Differences in Acinetobacter baumannii strains and host innate immune response determine morbidity and mortality in experimental pneumonia |
Q46420938 | Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant Acinetobacter baumannii strains from different European hospitals |
Q34487712 | Diversity and Clinical Impact of Acinetobacter baumannii Colonization and Infection at a Military Medical Center |
Q35065744 | Diversity and evolution of AbaR genomic resistance islands in Acinetobacter baumannii strains of European clone I. |
Q34906933 | Diversity in the major polysaccharide antigen of Acinetobacter baumannii assessed by DNA sequencing, and development of a molecular serotyping scheme |
Q48160362 | Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones |
Q33588614 | Do biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii? |
Q42268922 | Draft genome sequence of the hydrocarbon-degrading and emulsan-producing strain Acinetobacter venetianus RAG-1T |
Q46597761 | Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. |
Q33533993 | Exploring the evolutionary dynamics of plasmids: the Acinetobacter pan-plasmidome |
Q38593301 | Genomic and phenotypic characterization of the species Acinetobacter venetianus |
Q33820401 | Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (forme |
Q43444890 | High genotypic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis in the Czech Republic |
Q35690410 | Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii |
Q43146535 | Identification of Acinetobacter genomic species 13TU by sequence analysis of the 16S-23S rRNA gene spacer region |
Q33941452 | Identification of Acinetobacter isolates from species belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with monoclonal antibodies specific for O Antigens of their lipopolysaccharides |
Q36076032 | Identification of NDM-1 in a Putatively Novel Acinetobacter Species ("NB14") Closely Related to Acinetobacter pittii |
Q54486582 | Identification of non-fermenting Gram-negative bacteria of clinical importance by an oligonucleotide array. |
Q43602741 | Intercenter reproducibility of binary typing for Staphylococcus aureus |
Q42406658 | Lack of evidence for "Acinetobacter septicus" as a species different from Acinetobacter ursingii? |
Q53905704 | Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic. |
Q37776591 | Microbial systematics and taxonomy: relevance for a microbial commons |
Q48660700 | Microbiological material exchanges among scientists |
Q28552411 | Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center |
Q48053280 | Molecular and phenotypic characterization of Acinetobacter strains able to degrade diesel fuel |
Q42037228 | Multidrug-resistant Acinetobacter baumannii in veterinary clinics, Germany |
Q34316009 | Naturally transformable Acinetobacter sp. strain ADP1 belongs to the newly described species Acinetobacter baylyi |
Q34569042 | Nosocomial bacteremia due to an as yet unclassified acinetobacter genomic species 17-like strain |
Q54240663 | Occurrence of IMP-1 in non-baumannii Acinetobacter clinical isolates from Brazil. |
Q42934134 | Old Clinical Isolates of Acinetobacter seifertii in Brazil Producing OXA-58. |
Q36747446 | Oligonucleotide array-based identification of species in the Acinetobacter calcoaceticus-A. baumannii complex in isolates from blood cultures and antimicrobial susceptibility testing of the isolates |
Q36158751 | Phylogenetic and genomic diversity in isolates from the globally distributed Acinetobacter baumannii ST25 lineage |
Q38812200 | Phylogenetic signal in phenotypic traits related to carbon source assimilation and chemical sensitivity in Acinetobacter species |
Q34768735 | Reclassification of Acinetobacter grimontii Carr et al. 2003 as a later synonym of Acinetobacter junii Bouvet and Grimont 1986. |
Q46642958 | Repetitive-DNA-element PCR fingerprinting and antibiotic resistance of pan-European multi-resistant Acinetobacter baumannii clone III strains |
Q31158215 | Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region |
Q34042171 | Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii |
Q42693867 | The genome sequence of the hydrocarbon-degrading Acinetobacter venetianus VE-C3. |
Q33552298 | The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool |
Q31106653 | The success of acinetobacter species; genetic, metabolic and virulence attributes |
Q37624613 | The synthetic N-terminal peptide of human lactoferrin, hLF(1-11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumannii |
Q42088397 | Three-dimensional human skin equivalent as a tool to study Acinetobacter baumannii colonization |
Q30985248 | Understanding patterns of use and scientific opportunities in the emerging global microbial commons |
Q44992698 | Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species |
Q54450446 | Variations in colistin susceptibility among different species of the genus Acinetobacter. |
Search more.